| 000 | 04067nam a22005415i 4500 | ||
|---|---|---|---|
| 999 |
_c200457968 _d76180 |
||
| 003 | DE-He213 | ||
| 005 | 20231109085845.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 211216s2022 sz | s |||| 0|eng d | ||
| 020 | _a9783030851477 | ||
| 024 | 7 |
_a10.1007/978-3-030-85147-7 _2doi |
|
| 040 |
_aTR-AnTOB _beng _cTR-AnTOB _erda |
||
| 041 | _aeng | ||
| 060 | 0 | 0 | _aWH 260 |
| 072 | 7 |
_aMJ _2bicssc |
|
| 072 | 7 |
_aMJ _2bicssc |
|
| 072 | 7 |
_aMED038000 _2bisacsh |
|
| 072 | 7 |
_aMJ _2thema |
|
| 072 | 7 |
_aMJ _2thema |
|
| 096 | _aWH260EBK | ||
| 245 | 1 | 0 |
_aClinical Management of Acute Lymphoblastic Leukemia _h[electronic resource] : _bFrom Bench to Bedside / _cedited by Mark R. Litzow, Elizabeth A. Raetz. |
| 250 | _a1st ed. 2022. | ||
| 264 | 1 |
_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2022. |
|
| 300 | _a1 online resource | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _aTRANSLATIONAL SCIENCE -- Molecular pathways and targets in B cell progenitor acute lymphoblastic leukemia -- Genetic Mechanisms in T-Cell Acute Lymphoblastic Leukemia -- Minimal Residual Disease in Acute Lymphoblastic Leukemia – Techniques and Application -- THERAPEUTICS -- Treatment of Pediatric B and T cell ALL -- Treatment of Adult B and T cell Acute Lymphoblastic Leukemia: An Overview of Current Treatments and Novel Advances -- Acute Lymphoblastic Leukemia in Infants: A distinctive, high risk subtype of childhood ALL -- Treatment of Elderly Patients with Acute Lymphoblastic Leukemia -- Treatment of Childhood Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia -- Treatment of adult Philadelphia chromosome positive ALL -- Treatment of Ph-like ALL -- Prophylaxis and treatment of central nervous system (CNS) ALL -- Late effects of therapy of acute lymphoblastic leukemia -- NEW AND EXISTING MODALITIES OF THERAPY -- Monoclonal Antibody Based Treatment and Other New Agents for B-Lineage ALL -- New Agents for the Treatment of T-Cell ALL -- The development and management of treatment with chimeric-antigen receptor T cell (CAR-T) -- Hematopoietic Stem Cell Transplantation in Adults with Acute Lymphoblastic Leukemia (ALL) -- Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia. | |
| 520 | _aThis book provides a state-of-the-art overview of acute lymphoblastic leukemia (ALL). The first section of the book presents the translational science behind ALL, reviewing molecular pathways and targets in B- and T-cell ALL, as well as techniques and application of minimal residual disease testing. The second section spotlights ALL management strategies for patients across the spectrum, from infants to the elderly. The final section outlines current and new advances in ALL treatment, including new monoclonal antibodies and allogenic and autologous HSCT. Written by experts in the field, Clinical Management of Acute Lymphoblastic Leukemia: From Bench to Bedside is a valuable resource that will guide patient management, stimulate investigative efforts, and increase understanding of the biologic underpinnings of the disease. | ||
| 650 | 0 | _aInternal medicine. | |
| 650 | 1 | 4 | _aInternal Medicine. |
| 650 | 2 | 4 | _aInternal Medicine. |
| 653 | 0 | _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma -- therapy | |
| 653 | 0 | _aPrecursor Cell Lymphoblastic Leukemia-Lymphoma -- genetics | |
| 653 | 0 | _aCombined Modality Therapy -- methods | |
| 653 | 0 | _aTreatment Outcome | |
| 700 | 1 |
_aLitzow, Mark R. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 700 | 1 |
_aRaetz, Elizabeth A. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-030-85147-7 _3Springer eBooks _zOnline access link to the resource |
| 942 |
_2NLM _cEBK |
||